Landmark Research: The First Clinical Evidence in Mast Cell Disorders One of the most groundbreaking developments in this field comes from a landmark clinical study published in July 2025 in The American Journal of the Medical Sciences
Every CWMP enrollee gets access to the Clean Start Weight Loss Ketogenic/Intermittent Fasting program a complete, physician-delivered patient program with guidebooks, protocols, and an online patient course
Wettergren A, Petersen H, Orskov C, Christiansen J, Sheikh SP, Holst JJ
Understanding PlexusDx Dual-Compound Alternatives If monotherapy with semaglutide reaches its limit, PlexusDx offers GLP-Squared Injectiona carefully formulated dual compound combining semaglutide and tirzepatide that is not two separate drugs but rather a single compound engineered to activate both GLP-1 and GIP receptors in balanced proportion
Use of dual-energy technique provides more accurate results due to the capacity to correct the effect of fat in the bone marrow
Ozempic represents one of many innovative treatment options we provide to support your personal health journey